Geneos Wealth Management’s iShares Morningstar Small-Cap Value ETF ISCV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $568K | Hold |
7,255
| – | – | 0.01% | 697 |
|
|
2026
Q1 | $504K | Hold |
7,255
| – | – | 0.01% | 704 |
|
|
2025
Q4 | $497K | Hold |
7,255
| – | – | 0.01% | 666 |
|
|
2025
Q3 | $483K | Hold |
7,255
| – | – | 0.01% | 658 |
|
|
2025
Q2 | $445K | Buy |
7,255
+3,597
| +98% | +$210K | 0.01% | 747 |
|
|
2025
Q1 | $217K | Hold |
3,658
| – | – | 0.01% | 876 |
|
|
2024
Q4 | $232K | Hold |
3,658
| – | – | 0.01% | 789 |
|
|
2024
Q3 | $232K | Hold |
3,658
| – | – | 0.01% | 736 |
|
|
2024
Q2 | $212K | Hold |
3,658
| – | – | 0.01% | 692 |
|
|
2024
Q1 | $224K | Sell |
3,658
-404
| -10% | -$23.4K | 0.01% | 675 |
|
|
2023
Q4 | $241K | Hold |
4,062
| – | – | 0.01% | 635 |
|
|
2023
Q3 | $210K | Hold |
4,062
| – | – | 0.01% | 672 |
|
|
2023
Q2 | $219K | Sell |
4,062
-155
| -4% | -$7.97K | 0.01% | 663 |
|
|
2023
Q1 | $220K | Buy |
4,217
+5
| +0.1% | +$275 | 0.01% | 632 |
|
|
2022
Q4 | $219K | Buy |
4,212
+6
| +0.1% | +$316 | 0.01% | 603 |
|
|
2022
Q3 | $199K | Buy |
4,206
+6
| +0.1% | +$319 | 0.01% | 599 |
|
|
2022
Q2 | $214K | Sell |
4,200
-201
| -5% | -$11K | 0.01% | 727 |
|
|
2022
Q1 | $258K | Buy |
4,401
+1
| +0% | +$58 | 0.01% | 713 |
|
|
2021
Q4 | $261K | Hold |
4,400
| – | – | 0.01% | 768 |
|
|
2021
Q3 | $255K | Hold |
4,400
| – | – | 0.01% | 764 |
|
|
2021
Q2 | $258K | Sell |
4,400
-8,794
| -67% | -$518K | 0.01% | 742 |
|
|
2021
Q1 | $256K | Buy |
13,194
+7,887
| +149% | +$416K | 0.01% | 866 |
|
|
2020
Q4 | $299K | Buy |
5,307
+924
| +21% | +$38.8K | 0.01% | 683 |
|
|
2020
Q3 | $151K | Hold |
4,383
| – | – | 0.01% | 788 |
|
|
2020
Q2 | $144K | Buy |
4,383
+15
| +0.3% | +$490 | 0.01% | 766 |
|
|
2020
Q1 | $125K | Hold |
4,368
| – | – | 0.01% | 764 |
|
|
2019
Q4 | $209K | Buy |
4,368
+3
| +0.1% | +$138 | 0.01% | 687 |
|
|
2019
Q3 | $193K | Sell |
4,365
-465
| -10% | -$20.6K | 0.01% | 672 |
|
|
2019
Q2 | $220K | Hold |
4,830
| – | – | 0.01% | 637 |
|
|
2019
Q1 | $222K | Sell |
4,830
-300
| -6% | -$13.8K | 0.01% | 610 |
|
|
2018
Q4 | $209K | Hold |
5,130
| – | – | 0.02% | 586 |
|
|
2018
Q3 | $262K | Hold |
5,130
| – | – | 0.02% | 551 |
|
|
2018
Q2 | $260K | Hold |
5,130
| – | – | 0.02% | 493 |
|
|
2018
Q1 | $244K | Hold |
5,130
| – | – | 0.02% | 481 |
|
|
2017
Q4 | $260K | Buy |
5,130
+15
| +0.3% | +$741 | 0.02% | 465 |
|
|
2017
Q3 | $250K | Sell |
5,115
-750
| -13% | -$35.2K | 0.02% | 450 |
|
|
2017
Q2 | $275K | Hold |
5,865
| – | – | 0.03% | 418 |
|
|
2017
Q1 | $282K | Hold |
5,865
| – | – | 0.03% | 396 |
|
|
2016
Q4 | $279K | Hold |
5,865
| – | – | 0.04% | 382 |
|
|
2016
Q3 | $255K | Hold |
5,865
| – | – | 0.03% | 394 |
|
|
2016
Q2 | $239K | Hold |
5,865
| – | – | 0.03% | 403 |
|
|
2016
Q1 | $232K | Buy |
+5,865
| New | +$213K | 0.04% | 402 |
|
Other funds holding ISCV
ETC
VCS
SCM
MTC
Geneos Wealth Management's ISCV Position: Q2 2026 in Review
Geneos Wealth Management held its iShares Morningstar Small-Cap Value ETF (ISCV) position steady in Q2 2026 at 7,255 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #697.
Geneos Wealth Management first reported a position in ISCV in Q1 2016 and has held it in 42 quarters since. 131 funds tracked by Wall St. Rank hold ISCV as of Q2 2026.
- Geneos Wealth Management held 7,255 shares of iShares Morningstar Small-Cap Value ETF worth $568K as of Q2 2026.
- Geneos Wealth Management left its iShares Morningstar Small-Cap Value ETF share count unchanged in Q2 2026.
- iShares Morningstar Small-Cap Value ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #697 holding.
- Geneos Wealth Management first reported a position in iShares Morningstar Small-Cap Value ETF in Q1 2016 and has held it in 42 quarters since.
- 131 funds tracked by Wall St. Rank held iShares Morningstar Small-Cap Value ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.